Chicago Partners Investment Group LLC Has $1.33 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Key Points

• Chicago Partners Investment Group LLC increased its stake in Walgreens Boots Alliance by 23.1%, acquiring an additional 22,526 shares in the first quarter, totaling 120,141 shares valued at approximately $1,328,000.
• Walgreens Boots Alliance reported a quarterly earnings per share (EPS) of $0.38, surpassing analysts' estimates of $0.34, with a revenue increase of 7.2% year-over-year, totaling $38.99 billion.
• Analysts currently rate Walgreens Boots Alliance with a consensus of "Hold", with four sell ratings, seven hold ratings, and two buy ratings, along with a price target of $10.59.

Chicago Partners Investment Group LLC raised its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 23.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 120,141 shares of the pharmacy operator's stock after purchasing an additional 22,526 shares during the quarter. Chicago Partners Investment Group LLC's holdings in Walgreens Boots Alliance were worth $1,328,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP grew its position in Walgreens Boots Alliance by 5.9% in the fourth quarter. Wellington Management Group LLP now owns 204,979 shares of the pharmacy operator's stock valued at $1,912,000 after purchasing an additional 11,453 shares in the last quarter. Russell Investments Group Ltd. increased its position in shares of Walgreens Boots Alliance by 58.8% during the 4th quarter. Russell Investments Group Ltd. now owns 345,273 shares of the pharmacy operator's stock worth $3,218,000 after purchasing an additional 127,800 shares during the last quarter. Invesco Ltd. raised its stake in shares of Walgreens Boots Alliance by 8.8% during the 4th quarter. Invesco Ltd. now owns 32,572,567 shares of the pharmacy operator's stock worth $303,902,000 after purchasing an additional 2,631,332 shares in the last quarter. Scotia Capital Inc. raised its stake in shares of Walgreens Boots Alliance by 145.7% during the 4th quarter. Scotia Capital Inc. now owns 199,897 shares of the pharmacy operator's stock worth $1,866,000 after purchasing an additional 118,539 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its stake in shares of Walgreens Boots Alliance by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 314,834 shares of the pharmacy operator's stock valued at $2,937,000 after buying an additional 1,980 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Performance

WBA stock traded up $0.04 during trading hours on Friday, hitting $11.94. 7,572,244 shares of the stock were exchanged, compared to its average volume of 5,993,019. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $13.25. The company has a current ratio of 0.60, a quick ratio of 0.32 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $10.33 billion, a P/E ratio of -1.64, a P/E/G ratio of 1.40 and a beta of 0.80. The company has a 50-day simple moving average of $11.49 and a two-hundred day simple moving average of $11.10.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The business had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. During the same period in the prior year, the company posted $0.63 earnings per share. Walgreens Boots Alliance's revenue was up 7.2% compared to the same quarter last year. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on WBA. Wall Street Zen initiated coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Finally, UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.